Genetic variation in the alpha1B-adrenergic receptor and vascular response

A. Adefurin, L. V. Ghimire, U. Kohli, M. Muszkat, G. G. Sofowora, C. Li, R. T. Levinson, S. Y. Paranjape, C. M. Stein, D. Kurnik

Research output: Contribution to journalArticlepeer-review


The alpha 1B (α 1B)-adrenergic receptors contribute to vasoconstriction in humans. We tested the hypothesis that variation in the ADRA1B gene contributes to interindividual variability and ethnic differences in adrenergic vasoconstriction. We measured dorsal hand vein responses to increasing doses of phenylephrine in 64 Caucasians and 41 African Americans and genotyped 34 ADRA1B variants. We validated findings in another model of catecholamine-induced vasoconstriction, the increase in mean arterial pressure ("MAP) during a cold pressor test (CPT). One ADRA1B variant, rs10070745, present in 14 African-American heterozygotes but not in Caucasians, was associated with a lower phenylephrine ED 50 (geometric mean (95% confidence interval), 144 (69-299) ng ml 1) compared with 27 African-American non-carriers (208 (130-334) ng ml 1; P=0.015) and contributed to the ethnic differences in ED 50. The same variant was also associated with a greater "MAP during CPT (P=0.008). In conclusion, ADRA1B rs10070745 was significantly associated with vasoconstrictor responses after adrenergic stimulation and contributed to the ethnic difference in phenylephrine sensitivity.

Original languageEnglish
Pages (from-to)366-371
Number of pages6
JournalPharmacogenomics Journal
Issue number4
StatePublished - 1 Jul 2017

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Genetics
  • Pharmacology


Dive into the research topics of 'Genetic variation in the alpha1B-adrenergic receptor and vascular response'. Together they form a unique fingerprint.

Cite this